Home About Us News FUJIFILM Diosynth Biotechnologies to Showcase its AAV Platform to Rapidly Advance Gene Therapies at Biotech Week Boston

FUJIFILM Diosynth Biotechnologies to Showcase its AAV Platform to Rapidly Advance Gene Therapies at Biotech Week Boston


FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization for biologics, vaccines and advanced therapies, will be showcasing its viral vector platform for adeno-associated viral (AAV) vectors during the BioProcess International and Cell & Gene Therapy Manufacturing & Commercialization conferences, part of Biotech Week Boston, taking place September 27 – 30.

Additionally, we will be highlighting our local capabilities in Watertown, MA, USA, as well as the capabilities in Darlington, UK, focused on early-stage process development and cGMP manufacture. Our global, highly integrated gene therapy network also provides drug product services and commercial-scale manufacturing for gene therapy products and viral vaccines at its facility in College Station, TX, USA.

To learn more about FUJIFILM Diosynth Biotechnologies’ capabilities, schedule a meeting via ConnectMe, the event partnering app, or visit the team at Booth 219 at the Boston Convention and Exhibition Center.

Join our experts speaking at the following sessions:

  • On September 28th at 11:30 am Ian Goodwin, Director, Program Design, Advanced Therapies, will present “Strategies to Propel Your Viral Vector Therapy from Lab to Clinic”.
  • On September 29th at 11:15 am Josh Souther, Senior Scientist, will deliver the presentation on “Single-Use Recovery: Centrifugation and Depth Filtration”.

For more information, please visit the event section at fujifilmdiosynth.com

Viral vector platform: from gene to market

Our viral vector platform approach offers streamlined development leveraging triple transfection technology and ‘ready-to-go’ critical materials that can circumvent time, cost, and raw material access constraints reducing the timeline from gene to clinic and enabling rapid first-in-human clinical trials. For more information on our services within the advanced therapies, please visit our offerings site.

We welcome prospective clients and industry consultants to schedule a meeting and tour of our facilities via our company website.

About FUJIFILM Diosynth Biotechnologies
FUJIFILM Diosynth Biotechnologies, a subsidiary of FUJIFILM Corporation, is a world-leading contract development and manufacturing organization with experience in the development and manufacture of biologics, vaccines, and advanced therapies. The company operates a global network with major locations in the United States of America, the United Kingdom and Denmark and it is building a new manufacturing site in Holly Springs, North Carolina, USA.

For more information, please visit fujifilmdiosynth.com or follow us on LinkedIn and Twitter.